Range & Business models
Product range
- Solid Orals
- Liquid Orals
- Topical Applications
- Small Volume Parenterals
- Cytotoxic
Business mix
In-Licensing/Out-Licensing
- In licensed originator molecules from innovators across the globe for clinical trials, obtaining regulatory approvals and manufacturing in India
- In India promoting through large MNCs
- Globally, promoting through Pt.Kalbe (Indonesia), Pharmtech (Korea), Dankos (Malaysia), Nisch Pharma (Russia) and Darnitsa (Ukraine)
- Introduced a product containing Esterified fatty acid complex - effective in the treatment of Osteoarthritis and Rheumatoid arthritis
- Plans for more originator / innovator molecules for the treatment of Periodontal disease, Psoriasis in the pipeline.
Contract manufacturing support to MNCs and major Indian Companies Collaborative development
A key arm of our Pharma Division is in researching and collaborating for creating new drug delivery systems. Leveraging our expertise in synthesis our offerings are in:
Anti cancer:
- Collaborative project.
- Obtained the regulatory approval and WHO GMP certification
- Completed the validations of 11 products and already registered in Sri Lanka
- Initiated dossiers filings in association with, Darnitsa (Ukraine), Nisch Pharma (Russia) in Russia and CIS markets
Anti arthritis
- Collaborative project. Development of multi component anti-arthritic formulations